Johnson & Johnson announces positive results from phase 3b APEX study of Tremfya to treat adults living with active psoriatic arthritis: Spring House, Pennsylvania Monday, April 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback